Jump Financial LLC purchased a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 15,300 shares of the company's stock, valued at approximately $363,000.
Other large investors also recently bought and sold shares of the company. AlphaQuest LLC lifted its position in Surgery Partners by 112.0% in the first quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock valued at $25,000 after buying an additional 559 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Surgery Partners by 86.4% in the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after buying an additional 542 shares during the last quarter. Summit Securities Group LLC acquired a new position in Surgery Partners in the first quarter valued at about $31,000. DekaBank Deutsche Girozentrale acquired a new position in Surgery Partners in the first quarter valued at about $65,000. Finally, State of Wyoming lifted its position in Surgery Partners by 94.4% in the fourth quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after buying an additional 1,943 shares during the last quarter.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on SGRY shares. Bank of America started coverage on shares of Surgery Partners in a research note on Monday, July 28th. They set a "buy" rating and a $28.00 price target on the stock. Barclays cut their target price on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Surgery Partners has an average rating of "Moderate Buy" and a consensus target price of $33.00.
Check Out Our Latest Stock Analysis on Surgery Partners
Insider Buying and Selling at Surgery Partners
In other news, Director Teresa Deluca sold 20,018 shares of the stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $22.74, for a total value of $455,209.32. Following the completion of the sale, the director directly owned 45,173 shares of the company's stock, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.70% of the company's stock.
Surgery Partners Stock Up 0.7%
Surgery Partners stock traded up $0.15 during mid-day trading on Friday, hitting $22.51. The company had a trading volume of 1,035,308 shares, compared to its average volume of 1,283,239. The stock has a market cap of $2.89 billion, a price-to-earnings ratio of -15.74 and a beta of 1.76. Surgery Partners, Inc. has a 1 year low of $18.87 and a 1 year high of $33.90. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. The business has a fifty day moving average of $22.48 and a 200 day moving average of $22.66.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. The company had revenue of $826.20 million for the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm's revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.21 earnings per share. On average, sell-side analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.
Surgery Partners Company Profile
(
Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Further Reading

Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.